Seres Therapeutics Inc (MCRB)
0.7636
+0.14
(+22.25%)
USD |
NASDAQ |
Apr 23, 16:00
0.7636
0.00 (0.00%)
After-Hours: 18:30
Seres Therapeutics Enterprise Value: 67.90M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 67.90M |
| April 19, 2024 | 58.13M |
| April 18, 2024 | 61.80M |
| April 17, 2024 | 68.31M |
| April 16, 2024 | 69.64M |
| April 15, 2024 | 66.89M |
| April 12, 2024 | 72.44M |
| April 11, 2024 | 76.60M |
| April 10, 2024 | 77.68M |
| April 09, 2024 | 80.71M |
| April 08, 2024 | 84.18M |
| April 05, 2024 | 88.74M |
| April 04, 2024 | 87.61M |
| April 03, 2024 | 83.15M |
| April 02, 2024 | 88.77M |
| April 01, 2024 | 89.40M |
| March 28, 2024 | 90.48M |
| March 27, 2024 | 91.40M |
| March 26, 2024 | 87.14M |
| March 25, 2024 | 92.48M |
| March 22, 2024 | 89.68M |
| March 21, 2024 | 93.68M |
| March 20, 2024 | 99.11M |
| March 19, 2024 | 95.35M |
| March 18, 2024 | 88.09M |
| Date | Value |
|---|---|
| March 15, 2024 | 92.23M |
| March 14, 2024 | 88.50M |
| March 13, 2024 | 90.82M |
| March 12, 2024 | 90.31M |
| March 11, 2024 | 103.45M |
| March 08, 2024 | 120.13M |
| March 07, 2024 | 121.57M |
| March 06, 2024 | 126.10M |
| March 05, 2024 | 133.65M |
| March 04, 2024 | 145.73M |
| March 01, 2024 | 159.32M |
| February 29, 2024 | 139.51M |
| February 28, 2024 | 140.97M |
| February 27, 2024 | 139.51M |
| February 26, 2024 | 129.33M |
| February 23, 2024 | 127.87M |
| February 22, 2024 | 133.69M |
| February 21, 2024 | 126.41M |
| February 20, 2024 | 124.96M |
| February 16, 2024 | 126.41M |
| February 15, 2024 | 136.60M |
| February 14, 2024 | 133.69M |
| February 13, 2024 | 127.87M |
| February 12, 2024 | 140.97M |
| February 09, 2024 | 124.83M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
40.10M
Minimum
Jun 14 2019
3.170B
Maximum
Nov 17 2020
644.92M
Average
389.08M
Median
Mar 11 2022
Enterprise Value Benchmarks
| Integra Lifesciences Holdings Corp | 3.468B |
| Nuwellis Inc | -1.307M |
| Axogen Inc | 311.97M |
| Axsome Therapeutics Inc | 3.160B |
| 908 Devices Inc | 38.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -41.25M |
| Revenue (Quarterly) | 0.064M |
| Total Expenses (Quarterly) | 39.59M |
| EPS Diluted (Quarterly) | -0.32 |
| Profit Margin (Quarterly) | -64.45K% |
| Earnings Yield | -117.9% |
| Normalized Earnings Yield | -117.86 |